Related Experiment Video
Updated: Oct 28, 2026

Preoxygenation Techniques for Tracheal Intubation in Critically Ill Adults Utilizing Oxygen Mask and Noninvasive Ventilation
Published on: December 5, 2025
High-Flow Nasal Oxygenation Is Associated with Improved Respiratory Stability During Moderate Multimodal
Anita Vuković1, Tomislav Jukić2, Marija Štanfel2
1Department of Anesthesiology, Reanimatology and Intensive Care Unit, General Hospital Dubrovnik, 20000 Dubrovnik, Croatia.
Abstract:
Background/Objectives: High-flow nasal oxygenation (HFNO) may improve respiratory stability during procedural sedation, but treatment-associated differences across patient risk categories remain uncertain. We compared HFNO with low-flow nasal oxygenation (LFNO) during moderate multimodal analgosedation (MMAS) for pars plana vitrectomy (PPV) in patients with ASA physical status I-III. Methods: In this prospective, single-center randomized trial, 164 adults undergoing elective PPV under regional eye anesthesia with MMAS were randomized to HFNO (40 L·min-1, set FiO2 0.40) or LFNO (5 L·min-1, intended to approximate a nominal FiO2 of 0.40). Sedation depth was monitored using the Patient State Index and evaluated using the Ramsay Sedation Scale. The primary outcome was maintenance of target oxygenation (SpO2 94-98%) without hypoxemia (SpO2 < 90%), assessed by peripheral oxygen saturation (SpO2) at three predefined time points (T0, T1, and T2). Secondary outcomes included breathing frequency (BF), measured end-tidal CO2 (EtCO2), and clinically significant bradypnea (CSB), defined as ≥1 bradypnea episode (BF < 12 breaths·min-1 persisting ≥1 min) accompanied by SpO2 90-93%, EtCO2 > 45 mmHg, or both. Results: The primary outcome showed no between-group difference. No hypoxemia (SpO2 < 90%) occurred. Oxygenation below the target range (SpO2 90-93%) was less frequent with HFNO peri-procedurally (adjusted RR, 0.14; 95% CI, 0.03-0.56; p = 0.006) and post-procedurally (adjusted RR, 0.15; 95% CI, 0.04-0.64; p = 0.010). Significant treatment × ASA interactions were observed for BF and measured EtCO2 peri-procedurally. In exploratory ASA-stratified analyses, ASA III patients receiving HFNO had higher BF, fewer CSB episodes, and lower measured EtCO2 than those receiving LFNO. Conclusions: HFNO was associated with improved respiratory stability compared with LFNO, with treatment-associated differences varying across ASA strata.
Related Concept Videos
Administering Oxygen by Nasal Cannula
Nasal Cannulas
A nasal cannula is a lightweight tube split into two prongs placed in the nostrils, connected...
Oxygen Delivering System I: Nasal Cannula and Face Mask
Nasal Cannula
A nasal cannula is a lightweight tube split at one end into two prongs and placed in the nostrils. It is typically used to deliver low to medium levels of oxygen.
Suggested flow rate: The suggested flow rate for a nasal cannula typically ranges between 1 and 6 L/min.
Oxygen percentage setting:...
Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation (NIPPV)
Cardiopulmonary Resuscitation II: ACLS Airway Management

